Snapshot from Jun 09, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / Medpace faces securities fraud lawsuit
Regulatory class action lawsuit

Medpace faces securities fraud lawsuit

Analysis based on 7 articles · First reported May 22, 2026 · Last updated Jun 01, 2026

Sentiment
-50
Attention
4
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is negatively impacted by the news of a class action lawsuit against Medpace, as it suggests potential financial liabilities and reputational damage for Medpace. Investors who purchased Medpace securities during the class period may suffer losses.

Legal Services Biotechnology
Event Summary

The Schall Law Firm has filed a class action lawsuit against Medpace Holdings, Inc. for alleged violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. The lawsuit claims that Medpace made false and misleading statements to the market, engaging in a scheme to artificially inflate its share price between April 22, 2025, and February 9, 2026. Investors who suffered losses during this 'Class Period' are encouraged to join the lawsuit before June 5, 2026, to recover damages. The Schall Law Firm, led by Brian Schall, specializes in securities class action lawsuits and shareholder rights litigation.

Key Actions
100 The Schall Law Firm reminded investors of lawsuit Medpace
Entities Involved
stock
Medpace
Medpace is the defendant in a class action lawsuit for allegedly making false and misleading statements to inflate its share price, leading to investor losses.
Importance 100 Sentiment -70
priv
The Schall Law Firm
The Schall Law Firm is representing investors in a class action lawsuit against Medpace, encouraging shareholders to join the case to recover losses.
Importance 80 Sentiment 20
per
Brian Schall
Brian Schall is an attorney at The Schall Law Firm, encouraging investors to contact him regarding the class action lawsuit against Medpace.
Importance 60 Sentiment 10
govactor
United States — United States Securities and Exchange Commission
The United States — United States Securities and Exchange Commission's rules and acts are cited as the basis for the class action lawsuit against Medpace.
Importance 30 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.